Proactive Response to Loss of Brand Patent Protection
| Industry | Pharmaceutical Manufacturer |
| Problem | A brand manufacturer drug is losing patent protection in the next few years and wanted to understand the pricing strategies that generic manufacturers use when a product has 180-day market exclusivity and when multiple competitors enter the marketplace. The client was interested in brand erosion rates so that they could forecast the impact that generic competition would have on product sales. |
| PHSI Solution | PHSI identified the effect that 180-day exclusivity had on pharmacy cost during the exclusivity period, the effect when multiple generic competitors entered the market, and brand erosion rates. PHSI presented the findings to the manufacturer’s marketing and product teams. |
| Results | The well received information helped the brand teams project the impact that the introduction of a competitive generic product would have on product sales after loss of exclusivity. |
Poll Results
August 2023 Question of the Month
What steps do you take when learning about an electronic prescribing challenge?
Root cause analysis: 0%
Compendia review: 0%
Engage a partner: 0%
All of the above: 50%
None of the above: 50%
July 2023 Question of the Month
Does your organization have a strategy for Humira biosimilar launches?
Yes, well defined: 0%
We have a framework: 50%
Waiting for clarity: 0%
No: 0%
Unaware of need: 50%
June 2023 Question of the Month
How far in advance of NDA/BLA expected approval do (or should) manufacturers begin planning their compendia submission strategy?
During Phase II Trials: 0%
Initiation of Phase III Trials: 66%
6 months prior to approval: 33%
3 months prior to approval: 0%
At time of approval: 0%
After approval: 0%
No strategy: 0%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
